77545-45-0

Usage

Uses

Used in Pharmaceutical Industry:
3',6'-dichlorospiro[benzo[c][1,2]oxathiole-3,9'-xanthene] 1,1-dioxide is used as a potential pharmaceutical agent for its unique molecular structure and functional groups, which may offer specific reactivity and properties beneficial for drug development.
Used in Materials Science:
In the field of materials science, 3',6'-dichlorospiro[benzo[c][1,2]oxathiole-3,9'-xanthene] 1,1-dioxide is utilized for its potential to contribute to the development of new materials with distinct properties, owing to its complex molecular structure.
Used in Organic Synthesis:
3',6'-dichlorospiro[benzo[c][1,2]oxathiole-3,9'-xanthene] 1,1-dioxide serves as a key intermediate in organic synthesis, where its unique structure and functional groups can be leveraged to create novel compounds for various applications.
Note: The specific applications and reasons for use provided here are speculative, as the provided materials do not detail the exact uses of 3',6'-dichlorospiro[benzo[c][1,2]oxathiole-3,9'-xanthene] 1,1-dioxide. The potential uses listed are based on the general properties that such a complex molecule might possess. Further research and development would be required to confirm these applications.

Synthetic route

sulfonefluorescein (4424-03-7) → 3’,6’-dichlorospiro[3H-2,1-benzoxathiol-3,9’-[9H]xanthene]-1,1-dioxide (77545-45-0)

Conditions	Yield
With trichlorophosphate at 105℃; for 18h;	56%
With trichlorophosphate at 90℃; for 2h;	53.4 g
With trichlorophosphate at 90℃; for 2h;	53.4 g

sulfonfluorescein → 3’,6’-dichlorospiro[3H-2,1-benzoxathiol-3,9’-[9H]xanthene]-1,1-dioxide (77545-45-0)

Conditions	Yield
With phosphorus pentachloride at 125 - 130℃;

benzoyl chloride (98-88-4) + sulfonfluorescein → 3’,6’-dichlorospiro[3H-2,1-benzoxathiol-3,9’-[9H]xanthene]-1,1-dioxide (77545-45-0)

Conditions	Yield
at 200℃;

o-(6-hydroxy-3-oxo-3H-xanthen-9-yl)benzenesulphonic acid → 3’,6’-dichlorospiro[3H-2,1-benzoxathiol-3,9’-[9H]xanthene]-1,1-dioxide (77545-45-0)

Conditions	Yield
With thionyl chloride In N,N-dimethyl-formamide at 100℃; for 1h; Inert atmosphere;
With thionyl chloride

2-sulfobenzoic acid cyclic anhydride (81-08-3) → 3’,6’-dichlorospiro[3H-2,1-benzoxathiol-3,9’-[9H]xanthene]-1,1-dioxide (77545-45-0)

Conditions	Yield
Multi-step reaction with 2 steps 1: 0.5 h / 140 °C 2: trichlorophosphate / 2 h / 90 °C View Scheme

recorcinol (108-46-3) → 3’,6’-dichlorospiro[3H-2,1-benzoxathiol-3,9’-[9H]xanthene]-1,1-dioxide (77545-45-0)

Conditions	Yield
Multi-step reaction with 2 steps 1: 0.5 h / 140 °C 2: trichlorophosphate / 2 h / 90 °C View Scheme

saccharin (81-07-2) → 3’,6’-dichlorospiro[3H-2,1-benzoxathiol-3,9’-[9H]xanthene]-1,1-dioxide (77545-45-0)

Conditions	Yield
Multi-step reaction with 2 steps 1: sulfuric acid / sulfolane / 20 h / 120 - 140 °C 2: trichlorophosphate / 18 h / 105 °C View Scheme

3-amino-2,4,6-trimethylbenzenesulfonic acid sodium salt + C10H15NO2 + 3’,6’-dichlorospiro[3H-2,1-benzoxathiol-3,9’-[9H]xanthene]-1,1-dioxide (77545-45-0) → C39H37N2O8S2(1-)*Na(1+)

Conditions	Yield
Stage #1: 3-amino-2,4,6-trimethylbenzenesulfonic acid sodium salt; 3’,6’-dichlorospiro[3H-2,1-benzoxathiol-3,9’-[9H]xanthene]-1,1-dioxide With 1,8-diazabicyclo[5.4.0]undec-7-ene; magnesium chloride In ethylene glycol at 120℃; for 2h; Stage #2: C10H15NO2 In ethylene glycol at 150℃; for 5h;	95%

C12H18N2O + 3’,6’-dichlorospiro[3H-2,1-benzoxathiol-3,9’-[9H]xanthene]-1,1-dioxide (77545-45-0) → C43H44N4O6S

Conditions	Yield
With zinc(II) chloride In sulfolane at 180℃; for 6h; Solvent; Temperature;	94%

C11H16NO3S(1-)*Na(1+) + 3’,6’-dichlorospiro[3H-2,1-benzoxathiol-3,9’-[9H]xanthene]-1,1-dioxide (77545-45-0) + 2,6-dimethylaniline (87-62-7) → C38H35N2O7S2(1-)*Na(1+)

Conditions	Yield
Stage #1: C11H16NO3S(1-)*Na(1+); 3’,6’-dichlorospiro[3H-2,1-benzoxathiol-3,9’-[9H]xanthene]-1,1-dioxide With 1,8-diazabicyclo[5.4.0]undec-7-ene; magnesium triflate In ethylene glycol at 120℃; for 2h; Stage #2: 2,6-dimethylaniline In ethylene glycol at 150℃; for 5h;	94%

3-amino-2,4,6-trimethylbenzenesulfonic acid sodium salt + 3’,6’-dichlorospiro[3H-2,1-benzoxathiol-3,9’-[9H]xanthene]-1,1-dioxide (77545-45-0) + 2-(2-aminophenyl)propionitrile (88975-17-1) → C37H30N3O7S2(1-)*Na(1+)

Conditions	Yield
Stage #1: 3-amino-2,4,6-trimethylbenzenesulfonic acid sodium salt; 3’,6’-dichlorospiro[3H-2,1-benzoxathiol-3,9’-[9H]xanthene]-1,1-dioxide With 1,8-diazabicyclo[5.4.0]undec-7-ene; magnesium chloride In ethylene glycol at 120℃; for 2h; Stage #2: 2-(2-aminophenyl)propionitrile In ethylene glycol at 150℃; for 5h;	94%

C10H14NO3S(1-)*Na(1+) (1047719-94-7) + C10H12N2 + 3’,6’-dichlorospiro[3H-2,1-benzoxathiol-3,9’-[9H]xanthene]-1,1-dioxide (77545-45-0) → C39H36N3O7S2(1-)*Na(1+)

Conditions	Yield
Stage #1: C10H14NO3S(1-)*Na(1+); 3’,6’-dichlorospiro[3H-2,1-benzoxathiol-3,9’-[9H]xanthene]-1,1-dioxide With 1,8-diazabicyclo[5.4.0]undec-7-ene; magnesium chloride In ethylene glycol at 120℃; for 2h; Stage #2: C10H12N2 In ethylene glycol at 150℃; for 5h;	93%

C10H14NO5S(1-)*Na(1+) + 3’,6’-dichlorospiro[3H-2,1-benzoxathiol-3,9’-[9H]xanthene]-1,1-dioxide (77545-45-0) + 2,4,6-trimethylaniline (88-05-1) → C39H37N2O9S2(1-)*Na(1+)

Conditions	Yield
Stage #1: C10H14NO5S(1-)*Na(1+); 3’,6’-dichlorospiro[3H-2,1-benzoxathiol-3,9’-[9H]xanthene]-1,1-dioxide With 1,8-diazabicyclo[5.4.0]undec-7-ene; magnesium chloride In ethylene glycol at 120℃; for 2h; Stage #2: 2,4,6-trimethylaniline In ethylene glycol at 150℃; for 8h;	92%

C10H14NO5S(1-)*Na(1+) + C13H21NO3 + 3’,6’-dichlorospiro[3H-2,1-benzoxathiol-3,9’-[9H]xanthene]-1,1-dioxide (77545-45-0) → C42H43N2O12S2(1-)*Na(1+)

Conditions	Yield
Stage #1: C10H14NO5S(1-)*Na(1+); 3’,6’-dichlorospiro[3H-2,1-benzoxathiol-3,9’-[9H]xanthene]-1,1-dioxide With 1,8-diazabicyclo[5.4.0]undec-7-ene; magnesium chloride In ethylene glycol at 120℃; for 2h; Stage #2: C13H21NO3 In ethylene glycol at 150℃; for 5h;	92%

3-amino-2,4,6-trimethylbenzenesulfonic acid sodium salt + 3’,6’-dichlorospiro[3H-2,1-benzoxathiol-3,9’-[9H]xanthene]-1,1-dioxide (77545-45-0) + 2,4,6-trimethylaniline (88-05-1) → C37H33N2O7S2(1-)*Na(1+)

Conditions	Yield
Stage #1: 3-amino-2,4,6-trimethylbenzenesulfonic acid sodium salt; 3’,6’-dichlorospiro[3H-2,1-benzoxathiol-3,9’-[9H]xanthene]-1,1-dioxide With 1,8-diazabicyclo[5.4.0]undec-7-ene; magnesium chloride In ethylene glycol at 120℃; for 2h; Stage #2: 2,4,6-trimethylaniline In ethylene glycol at 150℃; for 5h;	92%

3’,6’-dichlorospiro[3H-2,1-benzoxathiol-3,9’-[9H]xanthene]-1,1-dioxide (77545-45-0) + 3,5-dimethylsulphanilic acid, sodium salt → C36H31N2O7S2(1-)*Na(1+)

Conditions	Yield
Stage #1: 3’,6’-dichlorospiro[3H-2,1-benzoxathiol-3,9’-[9H]xanthene]-1,1-dioxide; 3,5-dimethylsulphanilic acid, sodium salt With magnesium(II) chloride hexahydrate; 1,8-diazabicyclo[5.4.0]undec-7-ene In ethylene glycol at 120℃; Stage #2: 3,5-dimethylsulphanilic acid, sodium salt In ethylene glycol at 150℃; for 8h;	92%

C9H12NO3S(1-)*Na(1+) + 3’,6’-dichlorospiro[3H-2,1-benzoxathiol-3,9’-[9H]xanthene]-1,1-dioxide (77545-45-0) → C37H32N2O10S3(2-)*2Na(1+)

Conditions	Yield
With 1,8-diazabicyclo[5.4.0]undec-7-ene; magnesium chloride In ethylene glycol at 150℃; for 10h;	91%

4-trifluoromethylphenylamine (455-14-1) + 3’,6’-dichlorospiro[3H-2,1-benzoxathiol-3,9’-[9H]xanthene]-1,1-dioxide (77545-45-0) + 3,5-dimethylsulphanilic acid, sodium salt → C34H24F3N2O7S2(1-)*Na(1+)

Conditions	Yield
Stage #1: 3’,6’-dichlorospiro[3H-2,1-benzoxathiol-3,9’-[9H]xanthene]-1,1-dioxide; 3,5-dimethylsulphanilic acid, sodium salt With magnesium oxide; 1,8-diazabicyclo[5.4.0]undec-7-ene In ethylene glycol at 120℃; for 2h; Stage #2: 4-trifluoromethylphenylamine In ethylene glycol at 150℃; for 8h;	91%

p-toluidine (106-49-0) + 3’,6’-dichlorospiro[3H-2,1-benzoxathiol-3,9’-[9H]xanthene]-1,1-dioxide (77545-45-0) → C33H26N2O4S

Conditions	Yield
In ethylene glycol at 120℃; for 18h;	90.96%
In 1-methyl-pyrrolidin-2-one at 120℃; for 6h;

C14H20N2O + 3’,6’-dichlorospiro[3H-2,1-benzoxathiol-3,9’-[9H]xanthene]-1,1-dioxide (77545-45-0) → C47H48N4O6S

Conditions	Yield
With zinc(II) chloride In sulfolane at 150℃; for 8h;	90%

3’,6’-dichlorospiro[3H-2,1-benzoxathiol-3,9’-[9H]xanthene]-1,1-dioxide (77545-45-0) + 2,4,6-trimethylaniline (88-05-1) → C37H34N2O4S

Conditions	Yield
With zinc(II) chloride In sulfolane at 200℃; for 3h;	90%
In 1-methyl-pyrrolidin-2-one at 150℃; for 4h;	39%
Stage #1: 3’,6’-dichlorospiro[3H-2,1-benzoxathiol-3,9’-[9H]xanthene]-1,1-dioxide; 2,4,6-trimethylaniline With zinc(II) chloride In sulfolane at 200℃; for 3h; Stage #2: With hydrogenchloride In water; acetonitrile at 45℃; for 0.5h;	80.4 g
With zinc(II) chloride In sulfolane at 200℃; for 3h;	80 g
With zinc(II) chloride In sulfolane at 200℃; for 3h;	80 g

C10H14NO4S(1-)*Na(1+) + 3’,6’-dichlorospiro[3H-2,1-benzoxathiol-3,9’-[9H]xanthene]-1,1-dioxide (77545-45-0) → C39H36N2O12S3(2-)*2Na(1+)

Conditions	Yield
With 1,8-diazabicyclo[5.4.0]undec-7-ene; magnesium chloride In ethylene glycol at 150℃; for 10h;	90%

3-amino-2,4,6-trimethylbenzenesulfonic acid sodium salt + 3’,6’-dichlorospiro[3H-2,1-benzoxathiol-3,9’-[9H]xanthene]-1,1-dioxide (77545-45-0) → C37H32N2O10S3(2-)*2Na(1+)

Conditions	Yield
With 1,8-diazabicyclo[5.4.0]undec-7-ene; magnesium chloride In ethylene glycol at 150℃; for 10h;	90%

3-amino-2,4,6-trimethylbenzenesulfonic acid sodium salt + 2-methyl-6-pentafluoroethylaniline (273735-58-3) + 3’,6’-dichlorospiro[3H-2,1-benzoxathiol-3,9’-[9H]xanthene]-1,1-dioxide (77545-45-0) → C37H28F5N2O7S2(1-)*Na(1+)

Conditions	Yield
Stage #1: 3-amino-2,4,6-trimethylbenzenesulfonic acid sodium salt; 3’,6’-dichlorospiro[3H-2,1-benzoxathiol-3,9’-[9H]xanthene]-1,1-dioxide With 1,8-diazabicyclo[5.4.0]undec-7-ene; magnesium chloride In ethylene glycol at 120℃; for 2h; Stage #2: 2-methyl-6-pentafluoroethylaniline In ethylene glycol at 180℃; for 18h;	90%

3’,6’-dichlorospiro[3H-2,1-benzoxathiol-3,9’-[9H]xanthene]-1,1-dioxide (77545-45-0) + 3,5-dimethylsulphanilic acid, sodium salt → C35H28N2O10S3(2-)*2Na(1+)

Conditions	Yield
With 1,8-diazabicyclo[5.4.0]undec-7-ene; magnesium chloride In ethylene glycol at 150℃; for 10h;	90%

3’,6’-dichlorospiro[3H-2,1-benzoxathiol-3,9’-[9H]xanthene]-1,1-dioxide (77545-45-0) + diethylamine (109-89-7) → C31H40N3O3S(1+)

Conditions	Yield
In 1-methyl-pyrrolidin-2-one at 120℃; for 5h;	90%

3’,6’-dichlorospiro[3H-2,1-benzoxathiol-3,9’-[9H]xanthene]-1,1-dioxide (77545-45-0) + o-toluidine (95-53-4) → C33H26N2O4S

Conditions	Yield
With 1-methyl-2-pyridone at 120℃; for 8h;	89%
In 1-methyl-pyrrolidin-2-one at 150℃; for 4h;	45%

C10H14NO4S(1-)*Na(1+) + 3’,6’-dichlorospiro[3H-2,1-benzoxathiol-3,9’-[9H]xanthene]-1,1-dioxide (77545-45-0) → C39H36N2O12S3(2-)*2Na(1+)

Conditions	Yield
With 1,8-diazabicyclo[5.4.0]undec-7-ene; magnesium bromide In ethylene glycol at 150℃; for 10h;	89%

2,6-diisopropylbenzenamine (24544-04-5) + 3’,6’-dichlorospiro[3H-2,1-benzoxathiol-3,9’-[9H]xanthene]-1,1-dioxide (77545-45-0) → C43H46N2O4S

Conditions	Yield
With zinc(II) chloride In sulfolane at 200℃; for 4h;	88%
With magnesium chloride In sulfolane at 80 - 125℃; for 53h;	70.8%

2,6-diethyl-4-methylaniline (24544-08-9) + C11H16NO3S(1-)*Na(1+) + 3’,6’-dichlorospiro[3H-2,1-benzoxathiol-3,9’-[9H]xanthene]-1,1-dioxide (77545-45-0) → C41H41N2O7S2(1-)*Na(1+)

Conditions	Yield
Stage #1: C11H16NO3S(1-)*Na(1+); 3’,6’-dichlorospiro[3H-2,1-benzoxathiol-3,9’-[9H]xanthene]-1,1-dioxide With 1,8-diazabicyclo[5.4.0]undec-7-ene; magnesium bromide In ethylene glycol at 120℃; for 2h; Stage #2: 2,6-diethyl-4-methylaniline In ethylene glycol at 180℃; for 18h; Reagent/catalyst;	88%

3-Amino-2,4,6-trimethyl-phenol (114960-27-9) + 3’,6’-dichlorospiro[3H-2,1-benzoxathiol-3,9’-[9H]xanthene]-1,1-dioxide (77545-45-0) → C37H34N2O6S

Conditions	Yield
With sulfolane; zinc(II) chloride at 200℃; for 6h;	87%

C10H14NO5S(1-)*Na(1+) + 3’,6’-dichlorospiro[3H-2,1-benzoxathiol-3,9’-[9H]xanthene]-1,1-dioxide (77545-45-0) → C39H36N2O14S3(2-)*2Na(1+)

Conditions	Yield
With 1,8-diazabicyclo[5.4.0]undec-7-ene; magnesium bromide In ethylene glycol at 150℃; for 14h;	87%

C11H16NO3S(1-)*Na(1+) + C10H14NO4S(1-)*Na(1+) + 3’,6’-dichlorospiro[3H-2,1-benzoxathiol-3,9’-[9H]xanthene]-1,1-dioxide (77545-45-0) → C40H38N2O11S3(2-)*2Na(1+)

Conditions	Yield
Stage #1: C11H16NO3S(1-)*Na(1+); 3’,6’-dichlorospiro[3H-2,1-benzoxathiol-3,9’-[9H]xanthene]-1,1-dioxide With 1,8-diazabicyclo[5.4.0]undec-7-ene; magnesium bromide In ethylene glycol at 120℃; for 3h; Stage #2: C10H14NO4S(1-)*Na(1+) In ethylene glycol at 180℃; for 18h;	86%

3’,6’-dichlorospiro[3H-2,1-benzoxathiol-3,9’-[9H]xanthene]-1,1-dioxide (77545-45-0) + 2,6-dimethylaniline (87-62-7) → C35H30N2O4S

Conditions	Yield
With 1-methyl-2-pyridone at 150℃; for 8h; Darkness;	85%
With 1-methyl-2-pyridone In 1-methyl-pyrrolidin-2-one at 150℃; for 8h;	85%
With zinc(II) chloride In sulfolane at 200℃; for 4h;	65.6%

2,6-diethyl-4-methylaniline (24544-08-9) + 3’,6’-dichlorospiro[3H-2,1-benzoxathiol-3,9’-[9H]xanthene]-1,1-dioxide (77545-45-0) + 3,5-diisopropyl sulfanilic acid sodium salt → C42H43N2O7S2(1-)*Na(1+)

Conditions	Yield
Stage #1: 3’,6’-dichlorospiro[3H-2,1-benzoxathiol-3,9’-[9H]xanthene]-1,1-dioxide; 3,5-diisopropyl sulfanilic acid sodium salt With 1,8-diazabicyclo[5.4.0]undec-7-ene; magnesium bromide In ethylene glycol at 120℃; for 2h; Stage #2: 2,6-diethyl-4-methylaniline In ethylene glycol at 180℃; for 18h;	85%

3’,6’-dichlorospiro[3H-2,1-benzoxathiol-3,9’-[9H]xanthene]-1,1-dioxide (77545-45-0) + diethylamine (109-89-7) → C27H30N2O4S

Conditions	Yield
In isopropyl alcohol at 80℃; for 8h;	84%
In isopropyl alcohol at 80℃; for 8h;	84%
In isopropyl alcohol at 80℃; for 8h;	84%

3-amino-2,4,6-trimethylbenzenesulfonic acid sodium salt + 3’,6’-dichlorospiro[3H-2,1-benzoxathiol-3,9’-[9H]xanthene]-1,1-dioxide (77545-45-0) + 3,5-diisopropyl sulfanilic acid sodium salt → C40H38N2O10S3(2-)*2Na(1+)

Conditions	Yield
Stage #1: 3’,6’-dichlorospiro[3H-2,1-benzoxathiol-3,9’-[9H]xanthene]-1,1-dioxide; 3,5-diisopropyl sulfanilic acid sodium salt With 1,8-diazabicyclo[5.4.0]undec-7-ene; magnesium chloride In ethylene glycol at 120℃; for 3h; Stage #2: 3-amino-2,4,6-trimethylbenzenesulfonic acid sodium salt In ethylene glycol at 180℃; for 18h;	84%

Upstream product

• 81-07-2 saccharin 
• 4424-03-7 sulfonefluorescein 
• 108-46-3 recorcinol 
• 81-08-3 2-sulfobenzoic acid cyclic anhydride 
• 98-88-4 benzoyl chloride 

Downstream Products

• 60530-00-9 tetramethylsulforhodamine 
• 1201223-18-8 C₄₁H₃₆N₃O₅S⁽¹⁺⁾ 
• 1412432-09-7 C₄₅H₃₉N₄O₇S⁽¹⁺⁾*C₂F₃O₂^(1-) 
• 1412432-11-1 C₄₁H₃₇N₃O₅S 
• 1412432-08-6 C₃₅H₂₇N₂O₄S⁽¹⁺⁾*Cl^(1-) 

Relevant academic research and scientific papers

COLORING COMPOSITION, INK JET RECORDING INK, INK JET RECORDING METHOD, AND INK JET PRINTER CARTRIDGE

Provided are a coloring composition including a compound represented by Formula (1) shown in this specification and a compound represented by Formula (D) shown in this specification, an ink jet recording ink including the coloring composition, an ink jet recording method using the ink jet recording ink, and an ink jet printer cartridge that is filled with the ink jet recording ink.

KETONE INHIBITORS OF LYSINE GINGIPAIN

The present invention provides compounds according to Formula (I) as described herein, and their use for inhibiting the lysine gingipain protease (Kgp) from the bacterium Porphyromonas gingivalis. Also described are gingipain activity probe compounds and methods for assaying gingipain activity are also described, as well as methods for the treatment of disorders associated with P. gingivalis infection, including brain disorders such as Alzheimer's disease.

COLORED COMPOSITION, INKJET RECORDING INK, AND INKJET RECORDING METHOD

It is an object to provide a coloring composition which is excellent in moisture resistance, and is also excellent in hue, saturation and ozone resistance. Further, it is an object to provide an ink for inkjet recording, which includes the coloring composition, and an inkjet recording method using the ink for inkjet recording. A coloring composition including the compound represented by Formula (1) described in the specification and the compound selected from (A) to (C) described in the specification.

NOVEL COMPOUND HAVING MULTIMER STRUCTURE OF XANTHENE DERIVATIVE, COLORING COMPOSITION, INK FOR INKJET RECORDING, METHOD OF INKJET RECORDING, COLOR FILTER, AND COLOR TONER

There is provided a compound represented by formula (1): in formula (1), L represents a divalent to tetravalent linking group; D represents a residue obtained by removing 1 to 5 hydrogen atoms from a compound represented by formula (2); m represents an integer of 1 to 10, however, each L may be the same with or different from every other L; n represents an integer of 2 to 10, however, each D may be the same with or different from every other D; and in formula (2), each of R4 to R24 independently represents a hydrogen atom or a substituent, provided that formula (2) has at least one or more ionic hydrophilic groups.

Reversible off-on fluorescence probe for hypoxia and imaging of hypoxia-normoxia cycles in live cells

We report a fully reversible off-on fluorescence probe for hypoxia. The design employs QSY-21 as a F?rster resonance energy transfer (FRET) acceptor and cyanine dye Cy5 as a FRET donor, based on our finding that QSY-21 undergoes one-electron bioreduction to the radical under hypoxia, with an absorbance decrease at 660 nm. At that point, FRET can no longer occur, and the dye becomes strongly fluorescent. Upon recovery of normoxia, the radical is immediately reoxidized to QSY-21, with loss of fluorescence due to restoration of FRET. We show that this probe, RHyCy5, can monitor repeated hypoxia-normoxia cycles in live cells.